David Williams - Merck Ex Officer

MRCK34 Stock  BRL 77.28  2.55  3.41%   

Insider

David Williams is Ex Officer of Merck Co
Age 54
Phone908 740 4000
Webhttps://www.merck.com

David Williams Latest Insider Activity

Tracking and analyzing the buying and selling activities of David Williams against Merck stock is an integral part of due diligence when investing in Merck. David Williams insider activity provides valuable insight into whether Merck is net buyers or sellers over its current business cycle. Note, Merck insiders must abide by specific rules, including filing SEC forms every time they buy or sell Merck'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Merck Management Efficiency

The company has return on total asset (ROA) of 0.1268 % which means that it generated a profit of $0.1268 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.351 %, meaning that it generated $0.351 on every $100 dollars invested by stockholders. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities.
Merck Co has accumulated 30.69 B in total debt with debt to equity ratio (D/E) of 97.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Merck has a current ratio of 1.34, which is within standard range for the sector. Debt can assist Merck until it has trouble settling it off, either with new capital or with free cash flow. So, Merck's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Merck sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Merck to invest in growth at high rates of return. When we think about Merck's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Cari GallmanBristol Myers Squibb
N/A
Michael HenckeBiogen Inc
N/A
Michael CPABiogen Inc
59
David ElkinsBristol Myers Squibb
55
Deborah TelmanGilead Sciences
58
Timothy PowerBristol Myers Squibb
N/A
Sandra EsqBristol Myers Squibb
62
Michael QuigleyGilead Sciences
N/A
Jitendra TyagiBristol Myers Squibb
N/A
Nicole MurphyBiogen Inc
N/A
Linda HigginsGilead Sciences
61
Natacha GassenbachBiogen Inc
N/A
Diane WilfongGilead Sciences
61
Susan EsqBiogen Inc
66
Jacquie CFAGilead Sciences
N/A
Elizabeth SheaAbbVie Inc
N/A
Jyoti MehraGilead Sciences
47
BCH BMBristol Myers Squibb
57
Greg MeyersBristol Myers Squibb
50
Christopher ViehbacherBiogen Inc
63
Perry SiatisAbbVie Inc
N/A
It operates through four segments Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. MERCK DRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 69000 people. Merck Co (MRCK34) is traded on Sao Paulo Exchange in Brazil and employs 44 people.

Management Performance

Merck Leadership Team

Elected by the shareholders, the Merck's board of directors comprises two types of representatives: Merck inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck's management team and ensure that shareholders' interests are well served. Merck's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck's outside directors are responsible for providing unbiased perspectives on the board's policies.
Cristal Downing, Ex Officer
Jennifer Zachary, General Counsel
David Williams, Ex Officer
Caroline Litchfield, Ex CFO
Lisa LeCointeCephas, VP Officer
Richard DeLuca, Executive Vice President and Presidentident - Merck Animal Health
Kenneth Frazier, Chairman, CEO and Pres
Peter Dannenbaum, VP Relations
Jennifer Mauer, VP Communications
Robert JD, CEO Chairman

Merck Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merck a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Merck Stock

Merck financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck security.